Patents-Review.com
ClassID:

114235 ⎘

C12Y114/11016 - CPC Classification

Classification description:

Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11) Peptide-aspartate beta-dioxygenase (1.14.11.16), i.e. aspartyl (asparaginyl) beta-hydroxylase

Recent Application in this class:
#1
20250264470
2025-08-21

DIAGNOSIS, PROGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS

 #2
20210154283
2021-05-27

Aspartate-beta-hydroxylase Induces Epitope-specific T Cell Responses in Tumors

 #3
20200246443
2020-08-06

THERAPEUTIC CANCER VACCINE TARGETED TO HAAH (ASPARTYL-[ASPARAGINYL]-BETA-HYDROXYLASE)

 #4
20200190480
2020-06-18

ANTIBODIES AGAINST ASPARTYL (ASPARAGINYL) beta-HYDROXYLASE (AABH) AND METHODS OF MAKING AND USING

 #5
20180310863
2018-11-01

Automated medical sample collection, testing, and analysis

 #6
20180092969
2018-04-05

Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxylase

 #7
20170072034
2017-03-16

THERAPEUTIC CANCER VACCINE TARGETED TO HAAH (ASPARTYL-[ASPARAGINYL]-BETA-HYDROXYLASE)

 #8
20150306198
2015-10-29

Aspartate-β-hydroxylase induces epitope-specific T cell responses in tumors

 #9
20140271691
2014-09-18

Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylase)

 #10
20110124016
2011-05-26

Diagnosis and Treatment of Malignant Neoplasms

 #11
20100172832
2010-07-08

DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS

 #12
20100144837
2010-06-10

DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS

 #13
20100136581
2010-06-03

DIAGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS

 #14
20100093002
2010-04-15

Diagnosis and treatment of malignant neoplasms

 #15
20060211058
2006-09-21

Diagnosis and treatment of malignant neoplasms

 #16
20050123545
2005-06-09

Diagnosis and treatment of malignant neoplasms

 #17
20050113329
2005-05-26

Diagnosis and treatment of malignant neoplasms